Rare Treatments for Rare Dyslipidemias: New Perspectives in the Treatment of Homozygous Familial Hypercholesterolemia (HoFH) and Familial Chylomicronemia Syndrome (FCS)

PURPOSE OF REVIEW: This review aims to summarize the most recent published literature concerning lomitapide and volanesorsen that are approved for the use in HoFH and FCS patients, respectively. Moreover, it will briefly revise the published evidence on novel, non-approved treatments that are under...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Erasmo, Laura, Bini, Simone, Arca, Marcello
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Nonstatin Drugs (M. Vrablik, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410715/
https://www.ncbi.nlm.nih.gov/pubmed/34468855
http://dx.doi.org/10.1007/s11883-021-00967-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410715/
https://www.ncbi.nlm.nih.gov/pubmed/34468855
http://dx.doi.org/10.1007/s11883-021-00967-8

Ejemplares similares